Transforming Health Care Through Evidence and Collaboration
Transforming Health Care Through Evidence and Collaboration
Peter B. Bach, MD

In this briefing, Peter Bach discusses the need to find a balance between the cost of prescription drugs and incentives for innovation in the pharmaceutical industry. 

Joel Ario, JD

In this essay, Joel Ario explains Section 1332 waivers and lays out ways states could use this mechanism to put their own stamp on health reform.

Peter Shin, PhD, MPH

In this essay, Dr. Peter Shin presents highlights from his study of how community health centers are faring post-ACA, including the challenges of operating in states that chose not to expand Medicaid coverage. Shin also notes that critical federal funding could be in jeopardy after 2017 unless Congress takes action.

Judith Solomon, JD

In this essay, Judith Solomon updates the scorecard of state expansion decisions and presents the latest evidence on how the Medicaid expansion is affecting access to care, state budgets and insurance coverage.

Sabrina Corlette, JD

This essay takes a look at developments in the small group market since the passage of the ACA and highlights several issues that could threaten the long-term viability of this market as implementation moves forward.

Gail R. Wilensky, PhD

In this essay, Dr. Gail Wilensky, co-chair of that IOM committee, explains the recommendations and takes stock of the latest developments.

Miriam J. Laugesen, Ph.D.

In this essay, Miriam Laugesen peeks behind the scenes at the process used to develop work-value recommendations, assessing the accuracy of the RUC’s time estimates, noting flaws in the specialty society survey process, and highlighting ways to introduce greater precision and transparency to the task.

John Iglehart

In this essay, John Iglehart surveys the landscape for nurse practitioners, noting the latest developments in the scope of practice debate and showing where the tide might be turning.